Sebastian
Salvador de la Barrera
Universitat de les Illes Balears
Palma, EspañaPublicaciones en colaboración con investigadores/as de Universitat de les Illes Balears (1)
2024
-
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury
Spinal Cord, Vol. 62, Núm. 8, pp. 454-467